We are a group of highly qualified medical pathologists and scientists. We are passionate about actualizing meaningful research results and benefiting our peers in their goals. We offer our expertise to take responsibility for every step of your project including goals, design and execution. From the first conference call to project completion and beyond, you will interact with our thought leaders directly. This will ensure on-target project delivery that consistently exceeds expectations.

Our dedication to perfecting high-quality processes and the value we place on positive customer service experiences has earned GLAS an ISO 9001:2015 certification.

In August 2019, GLAS was acquired by Precision for Medicine, part of Precision Medicine Group. In joining Precision, GLAS is teaming up to strategically alter the course, pace, and quality of research— providing an unrivaled level of scientific understanding, high-quality specimens, and global scale. To learn more about our expanded capabilities, please visit: precisionbiospecimens.com.

Our Mission

Bridging the Gap between the research community and leading clinical care facilities to streamline research and end cancer in our lifetime.

GLAS strives to optimally leverage the combined intellectual and material resources of pathology groups, laboratorians and scientists around the country in order to provide the highest quality biospecimens and consultation to our clients.

Learn More About Our Values


Meet Our Executive Team

Cullen Taylor, MD

Dr. Taylor is our lead Medical Pathologist and the founding member of our company. GLAS was formed through his realization that forward-thinking pathologists and laboratorians should play a critical role as society works synchronously to realize the promise of translational medicine. Currently, this tremendous pool of valuable resources is underutilized.

Michelle Taylor

Michelle is our Director of Business Operations. She obtained her BSN and practiced for several years in the clinical care of patients, including critically ill bone marrow transplant recipients. This clinical experience combined with a cancer diagnosis impacting her own family potentiated her desire to join the GLAS team and work toward a better understanding of these diseases. Her roles in GLAS include financials, regulations and compliance. Her work ethic, attention to detail and upbeat personality make her a valuable member of the GLAS team. You may contact Michelle at mtaylor77@glas.bio

Recent blog posts

  • Precision for Medicine Launches Biospecimen Solutions Offering with Acquisition of ProMedDx and GLAS

    Addition of leading suppliers bolsters Precision’s biomarker service offerings — bringing unparalleled science, scale, and service to the biospecimen industry.

  • ISO 9001 certificate

    GLAS/ is ISO 9001 certified! That certificate looks fantastic!
Read More